2024-08-25 - Analysis Report
##  ABBV Stock Analysis Report

**Company Overview:** AbbVie Inc. (ABBV) is a research-based global biopharmaceutical company that develops and markets a broad range of medicines in various therapeutic areas.

**1. Performance vs. S&P 500:**
* **Cumulative Return:** ABBV: 120.22%, VOO (S&P 500): 71.75%
* **Outperformance:** ABBV has outperformed the S&P 500 by 48.41%. This represents a relative outperformance of 88.62% based on historical data.

**2. Recent Price Action:**
* **Closing Price:** $197.55
* **Moving Averages:**
    * 5-Day: $196.69
    * 20-Day: $190.81
    * 60-Day: $176.57

**3. Technical Indicators:**
* **RSI:** 73.07 (Overbought territory)
* **PPO:** -0.0 (Neutral)
* **Relative Divergence:** 10.33 (-): Indicates a potential short-term downward trend.

**4. Recent Earnings and Outlook:**

| Date       | EPS       | Expected EPS |
|------------|-----------|--------------|
| 2024-07-25 | 2.65      | 2.57         |
| 2024-04-26 | 2.31      | 2.26         |
| 2024-02-02 | 2.79      | 2.76         |
| 2023-10-27 | 2.95      | 2.86         |
| 2023-07-27 | 2.91      | 2.79         |

* **Most Recent Earnings:** ABBV exceeded earnings expectations for the quarter ending July 25th, 2024, with an EPS of $2.65 versus an expected $2.57.  The company has consistently exceeded earnings estimates in recent quarters.

**5. Overall Analysis:**

ABBV has demonstrated strong performance, significantly outperforming the S&P 500 over the long term. Its recent price action suggests a potential short-term downward trend, as evidenced by its overbought RSI and negative relative divergence. However, ABBV's strong earnings performance and consistent beatings of earnings expectations indicate a solid underlying business with a promising future.

**6. Conclusion:**

ABBV remains a strong performer with a solid track record of exceeding expectations. While technical indicators suggest a potential short-term pullback, its strong fundamentals and consistent earnings performance make it a compelling investment option for long-term investors. 
